Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-7-9
pubmed:abstractText
In this study, the phenotype, TCR signaling events, and function of T cells developed de novo during adulthood in the presence of extrathymic alloantigen were investigated. C57BL/6 mice(H-2b) were first transplanted heterotopically with BALB/c hearts (H-2d) and treated with rapamycin for 2 wk to create a tolerant status. Three weeks postoperation, the mice were whole body irradiated and transplanted with bone marrow cells from 2C mice, which are transgenic for TCR, and most of their T cells are Ld-specific CD8 cells. The 2C T cells developed de novo in the C57BL/6 mice were not able to reject the heart allograft. No clonal deletion, TCR down-regulation, or CD8 down-regulation was found in the tolerized 2C T cells. There was no characteristic phenotype of these cells in terms of CD25, ICAM-1, CD44, and MEL-14 expression. Early TCR signaling events such as intracellular calcium concentration flux, tyrosine phosphorylation, Lck and Fyn kinase activities, and Lck and Fyn protein levels in the tolerized 2C T cells were comparable to their normal counterparts, but the tolerized T cells were defective in IL-2 production and proliferation upon H-2d alloantigen stimulation in vitro. Exogenous IL-2 could not reverse the compromised proliferation. The results of this study indicate that during adulthood, the de novo-developed T cells become tolerant to extrathymic Ag without clonal deletion. These newly minted T cells are functionally defective although they are indistinguishable from normal T cells in phenotypes and in some early signaling events.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
161
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-82
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9647209-Animals, pubmed-meshheading:9647209-Antigens, CD44, pubmed-meshheading:9647209-Bone Marrow Transplantation, pubmed-meshheading:9647209-Cell Differentiation, pubmed-meshheading:9647209-Epitopes, T-Lymphocyte, pubmed-meshheading:9647209-H-2 Antigens, pubmed-meshheading:9647209-Heart Transplantation, pubmed-meshheading:9647209-Immune Tolerance, pubmed-meshheading:9647209-Immunocompromised Host, pubmed-meshheading:9647209-Intercellular Adhesion Molecule-1, pubmed-meshheading:9647209-Interleukin-2, pubmed-meshheading:9647209-Isoantigens, pubmed-meshheading:9647209-Lymphocyte Activation, pubmed-meshheading:9647209-Male, pubmed-meshheading:9647209-Mice, pubmed-meshheading:9647209-Mice, Inbred BALB C, pubmed-meshheading:9647209-Mice, Inbred C57BL, pubmed-meshheading:9647209-Mice, Transgenic, pubmed-meshheading:9647209-Radiation Chimera, pubmed-meshheading:9647209-Receptors, Interleukin-2, pubmed-meshheading:9647209-Signal Transduction, pubmed-meshheading:9647209-T-Lymphocytes
pubmed:year
1998
pubmed:articleTitle
De novo-developed T cells have compromised response to existing alloantigens: using Ld-specific transgenic 2C T cells as tracers in a mouse heart transplantation model.
pubmed:affiliation
The Louis-Charles Simard Research Center, Notre-Dame Hospital, CHUM, University of Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't